An Open-Label Trial of OROS Methylphenidate in Adults with Late-Onset ADHD
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Introduction: Many adults with current impairing symptoms of attention-deficit/hyperactivity disorder (ADHD) do not report an age at onset before 7 years of age and cannot, therefore, be assigned the full Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)diagnosis of ADHD. We hypothesized that treatment with oral-release osmotic system (OROS) methylphenidate (MPH) will be safe and efficacious for the treatment of adults with late-onset ADHD. Method: This was a 6-week, open-label, prospective treatment study of OROS MPH monotherapy in 36 adult patients with late-onset ADHD (onset later than the required 7 years of age) using standardized instruments for diagnosis and a robust oral daily dose of up to 1.3 mg/kg/day. Symptom severity was assessed with the Adult ADHD Investigator Symptom Report Scale (AISRS) and the Clinical Global Impression (CGI) scale. Results: Subjects reported robust current symptoms of ADHD at pre-treatment baseline (11.1±2.8 DSM-IV symptoms), but had an atypical mean age at onset of 14.2±8.6 years. Treatment with OROS MPH at an average daily dose of 78.2±29.4 mg was associated with a statistically and clinically significant reduction in ADHD symptoms relative to baseline as assessed through the AISRS (−16.4±10.5;P<.001). Using a categorical definition of response (CGI-I much or very much improved), a majority (n=26; 72%) of subjects were rated as improved at endpoint. Conclusion: These results extend previous findings in adults with full ADHD to adults meeting criteria for late-onset ADHD and support the need for further controlled clinical trials in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, T. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180020004 · Cited by 402
Self-citationSpencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385 · cited 1×
“8(22) 2(6) 1(3) 4(14) 6(17) 3(8) 25 (67) 23 (64) 12(33)”
Self-citationGender effects on Attention-Deficit/Hyperactivity disorder in adults, revisited
Biederman, J., Faraone, S. V., Monuteaux, M. C., Bober, M., & Cadogen, E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.003 · Cited by 385
Self-citationGenetics of adult attention-deficit/hyperactivity disorder
Faraone, S. V. (2004) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00090-x · Cited by 166
Brain function and structure in adults with attention-deficit/hyperactivity disorder
Seidman, L. J., Valera, E. M., & Bush, G. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.01.002 · Cited by 106
Rapport, M. D., Jones, J. T., DuPaul, G. J., Kelly, K. L., Gardner, M. J., Tucker, S. B., & Shea, M. S. (1987) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp1604_6 · Cited by 91
Bouffard, R., Hechtman, L., Minde, K., & Iaboni-Kassab, F. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800806 · Cited by 81
Cited by
The Age at Onset of Attention Deficit Hyperactivity Disorder
Kieling, C., Kieling, R. R., Rohde, L. A., Frick, P. J., Moffitt, T., Nigg, J. T., Tannock, R., & Castellanos, F. X. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09060796 · Cited by 185
Adler, L. A., Zimmerman, B., Starr, H. L., Silber, S., Palumbo, J., Orman, C., & Spencer, T. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a390ce · Cited by 106
Self-citationAttention-Deficit/Hyperactivity Disorder in Adults: Evidence-Based Recommendations for Management
Rostain, A. L. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1905 · Cited by 50
Fallu, A., Richard, C., Prinzo, R., & Binder, C. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x154132 · Cited by 42
Reinhardt, M. C., Benetti, L., Victor, M. M., Grevet, E. H., Belmonte-de-Abreu, P., Faraone, S. V., & Rohde, L. A. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0720 · Cited by 36
Metadata
- Authors
- Biederman, J., Mick, E., Spencer, T., Surman, C., Hammerness, P., Doyle, R., Dougherty, M., Aleardi, M., & Schweitzer, K.
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2006-05
- Volume
- 11
- Issue
- 5
- Pages
- 390-396
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W2405507916
- Cited by
- 37
- References
- 7
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Open-Label Trial of OROS Methylphenidate in Adults with Late-Onset ADHD. https://app.cochat.ai/papers/10.1017/s1092852900014528
- The paper
- Biederman, J., Mick, E., Spencer, T., Surman, C., Hammerness, P., Doyle, R., Dougherty, M., Aleardi, M., & Schweitzer, K. (2006). An Open-Label Trial of OROS Methylphenidate in Adults with Late-Onset ADHD. CNS Spectrums. https://doi.org/10.1017/s1092852900014528
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.